4/22/2024 0 Comments Moca test score of 2930![]() ![]() ![]() ![]() the invention further consists in brain specific IncRNAs altered in patient with brain disease in particular cognitive disorder and representing a diagnostic or therapeutic candidate for their treatment.the invention further relates to associated kits, methods, protocols and transmittable forms of information for diagnosis purposes and/or for other human medicine applications including the patient stratification in clinical trials and/or monitoring the efficacy of therapeutic strategies using this biomarker and peripheral body fluids or whole blood from patients.This invention relates to a biomarker for brain disorders, such as cognitive disorders, consisting in long non-coding RNAs (IncRNAs) in a peripheral circulating body fluid such as plasma or blood and/or expressed in brain tissue and/or whole blood and representing a therapeutic target for brain disorders, or non-invasive method for diagnosing brain disorders such as cognitive disorders, in particular Alzheimer's disease or for monitoring its development or progression using this biomarker.the present invention relates to the field of human medicine and specifically to the diagnostic and therapeutic of brain disorders and particularly cognitive disorders including those with mild cognitive impairment, Alzheimer disease, dementia with Lewy body and frontotemporal dementia.C12Q2600/178- Oligonucleotides characterized by their use miRNA, siRNA or ncRNA.C12Q2600/00- Oligonucleotides characterized by their use.primers or probes for diseases caused by alterations of genetic material C12Q1/6883- Nucleic acid products used in the analysis of nucleic acids, e.g.C12Q1/6876- Nucleic acid products used in the analysis of nucleic acids, e.g.C12Q1/68- Measuring or testing processes involving enzymes, nucleic acids or microorganisms Compositions therefor Processes of preparing such compositions involving nucleic acids.C12Q1/00- Measuring or testing processes involving enzymes, nucleic acids or microorganisms Compositions therefor Processes of preparing such compositions.C12Q- MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS COMPOSITIONS OR TEST PAPERS THEREFOR PROCESSES OF PREPARING SUCH COMPOSITIONS CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES.C12- BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION OR GENETIC ENGINEERING.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Application filed by Amoneta Diagnostics SAS filed Critical Amoneta Diagnostics SAS Priority to US17/274,019 priority Critical patent/US20210269881A1/en Publication of US20210269881A1 publication Critical patent/US20210269881A1/en Status Pending legal-status Critical Current Links Original Assignee Amoneta Diagnostics SAS Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Pending Application number US17/274,019 Inventor Saliha Moussaoui Hueseyin Firat Eric Schordan Current Assignee (The listed assignees may be inaccurate. Google Patents Long non-coding rnas (lncrnas) for the diagnosis and therapeutics of brain disorders, in particular cognitive disordersÄownload PDF Info Publication number US20210269881A1 US20210269881A1 US17/274,019 US201917274019A US2021269881A1 US 20210269881 A1 US20210269881 A1 US 20210269881A1 US 201917274019 A US201917274019 A US 201917274019A US 2021269881 A1 US2021269881 A1 US 2021269881A1 Authority US United States Prior art keywords lnc tcons lncrnas signature incrnas Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US20210269881A1 - Long non-coding rnas (lncrnas) for the diagnosis and therapeutics of brain disorders, in particular cognitive disorders US20210269881A1 - Long non-coding rnas (lncrnas) for the diagnosis and therapeutics of brain disorders, in particular cognitive disorders ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |